+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Drugs Market Research Reports

SGLT2 Inhibitors Market - Global Strategic Business Report - Product Thumbnail Image

SGLT2 Inhibitors Market - Global Strategic Business Report

  • Report
  • September 2026
  • 177 Pages
  • Global
From
Prediabetes Market - Global Strategic Business Report - Product Thumbnail Image

Prediabetes Market - Global Strategic Business Report

  • Report
  • September 2026
  • 287 Pages
  • Global
From
Liraglutide and Semaglutide - Global Strategic Business Report - Product Thumbnail Image

Liraglutide and Semaglutide - Global Strategic Business Report

  • Report
  • September 2026
  • 451 Pages
  • Global
From
From
DPP-IV Inhibitors - Global Strategic Business Report - Product Thumbnail Image

DPP-IV Inhibitors - Global Strategic Business Report

  • Report
  • September 2026
  • 82 Pages
  • Global
From
Incretin Mimetics Global Market Report 2026 - Product Thumbnail Image

Incretin Mimetics Global Market Report 2026

  • Report
  • May 2026
  • 250 Pages
  • Global
From
Once-Weekly Basal Insulin Therapy Market Global Report 2026 - Product Thumbnail Image

Once-Weekly Basal Insulin Therapy Market Global Report 2026

  • Report
  • April 2026
  • 250 Pages
  • Global
From
Oral Hypoglycemic Agents Market Report 2026 - Product Thumbnail Image

Oral Hypoglycemic Agents Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Liraglutide Market Report 2026 - Product Thumbnail Image

Liraglutide Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Dulaglutide Market Report 2026 - Product Thumbnail Image

Dulaglutide Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Octreotide Market Report 2026 - Product Thumbnail Image

Octreotide Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Insulin Aspart Market Report 2026 - Product Thumbnail Image

Insulin Aspart Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2026 - Product Thumbnail Image

Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Insulin Therapies for Diabetes Market Report 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin. Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more